Topical Application of PRF Before Radiation Therapy

ConditionPRF
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Giessen

About this trial

The primary goal of this study is to observe whether PRP promotes the wound healing before a radiation therapy or not, compared to the natural healing of a tooth extraction socket.

Secondary aim is to monitore the effect on the pain perception.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Head and neck cancer with planed radiation therapy

Bilateral tooth extraction

Similar tooth size

Atraumatic tooth extractions without flap surgery

Disqualifiers

Prior radiation therapy in the head and neck area

Prior and current therapy with bisphosphonates or equivalent modern biologics

Patients during pregnancy or breastfeeding

Trial design

Design model

Single group

Treatments tested in this trial

  • PRF

    Procedure/Surgery

    Patients blood is standardized centrifuged and split in to a red-phase (erythrocytes) and white-phase (PRF). The gained PRF is processed to a clot-fort and is inserted into the alveolus.

  • Natural Healing

    Procedure/Surgery

    After the tooth extraction, natural healing is aimed by allowing a blood clot formation without any further intervention.

Treatment groups

34 Participants
are divided into 2 treatment groups
Group A: PRF site (test site)Experimental treatment 1 intervention
Group B: Blood clot (control site)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Wound healing between the two sites using the Wound Healing Index

To compare the wound heeling, a modified Landry and Turnbull Healing Index is used. This index varies from 0 to 5, where 0 means no healing and 5 excellent healing.

Time frame
around 4 Weeks

Secondary outcomes

1

PRF and Pain perception

To compare pain perception between the two sites - the PRF test site and the control site - a visual analogue scale (VAS) for pain is provided to the patients. This scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the highest imaginable pain for the patient.

Time frame
around 7 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.